Trends in Pharmacological Sciences
K+ channels as targets for specific immunomodulation
Section snippets
Molecular interactions at the immunological synapse
The T-cell-mediated immune response is initiated by recognition of processed antigenic peptide bound to major histocompatibility complex (MHC) proteins on antigen-presenting cells (APCs) by the antigen-specific multi-subunit T-cell receptor (TCR)–CD3 complex on T cells (Figure 2). Within minutes the TCR–CD3 complex and accessory proteins cluster at the zone of contact with the APC in a region termed the ‘immunological synapse’ (IS). Antigen-induced redistribution of key receptors and signaling
Pharmacology of Kv1.3 and IKCa1 channels
The roles of Kv1.3 and IKCa1 channels have been defined in T cells with the help of structurally diverse peptides, small molecules and metal ions that block these channels with potencies ranging from picomolar to millimolar values. Figure 3, Figure 4 display the chemical structures of selected peptide and small organic inhibitors, whereas Table 1, Table 2 provide lists of Kv1.3 and IKCa1 channel modulators in order of decreasing potency. For Kv1.3, but not IKCa1, channels the potency of peptide
K+ channels in T cells: targets for immunomodulation
The immunomodulatory effects of channel blockers depend on the expression levels of Kv1.3 and IKCa1 channels, which change dramatically when T cells transition from resting to activated cells, and during differentiation from the naı̈ve to the memory state 15, 40, 56. Figure 5a shows the three human T-cell subsets that are distinguished based on the expression of the chemokine receptor CCR7 and the phosphatase CD45RA [57]: naı̈ve cells (CCR7+CD45RA+); central memory cells (TCM) (CCR7+CD45RA−);
Concluding remarks
Much work remains to be done to bring IKCa1 and Kv1.3 channel blockers to the clinic. The situation with small-molecule IKCa1 channel blockers is encouraging because ICA17043 is already in Phase II clinical trials for sickle cell disease and TRAM34 has been used successfully in an in vivo animal trial [54]. Both these agents and the newly described 4-phenyl-4H-pyran need to be evaluated in animal models of organ graft rejection, acute active EAE and rheumatoid arthritis.
Existing small-molecule
References (83)
A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes
J. Biol. Chem.
(1997)Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1
J. Biol. Chem.
(1999)Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation
J. Biol. Chem.
(1996)Human homologue of the Drosophila discs large tumor suppressor binds to p56lck tyrosine kinase and Shaker type Kv1.3 potassium channel in T lymphocytes
J. Biol. Chem.
(1997)Internalization of the Kv1.4 potassium channel is suppressed by clustering interactions with PSD-95
J. Biol. Chem.
(2000)The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency
J. Biol. Chem.
(1994)Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes. Evidence for association with the voltage-gated K+ channel
J. Biol. Chem.
(1991)ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide
J. Biol. Chem.
(1998)Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels
J. Biol. Chem.
(1993)A novel fluorescent toxin to detect and investigate Kv1.3-channel up-regulation in chronically activated T lymphocytes
J. Biol. Chem.
(2003)
Potent Nor-triterpenoid blockers of the voltage-gated potassium channel Kv1.3 from Spachea correae
Tetrahedron Lett.
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels
Cell. Immunol.
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice
Blood
Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel IKCa1
J. Biol. Chem.
4-Phenyl-4H-pyrans as IKCa channel blockers
Bioorg. Med. Chem. Lett.
Up-regulation of the IKCa1 potassium channel during T-cell activation: molecular mechanism and functional consequences
J. Biol. Chem.
Potassium channel KV 1 subunit expression and function in human detrusor muscle
J. Urol.
The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia
Biochim. Biophys. Acta
Ion channels and B cell mitogenesis
Mol. Immunol.
Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer
Life Sci.
Nicotine suppresses gastric wound repair via the inhibition of polyamine and K+ channel expression
Eur. J. Pharmacol.
Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells
J. Biol. Chem.
Potassium channels and vascular proliferation
Vascul. Pharmacol.
Unidirectional K+ fluxes in rat thymocytes stimulated by concanavalin A
J. Cell. Physiol.
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?
Nature
K+ channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion
Nature
Potassium current in clonal cytotoxic T lymphocytes from the mouse
J. Physiol.
Voltage-gated potassium channels are required for human T lymphocyte activation
J. Exp. Med.
Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes
J. Gen. Physiol.
Potassium channels in T lymphocytes: toxins to therapeutic immunosuppressants
Toxicon
Expression and chromosomal localization of a lymphocyte K+ channel gene
Proc. Natl. Acad. Sci. U. S. A.
Characterization and functional expression of a rat genomic DNA clone encoding a lymphocyte potassium channel
J. Immunol.
Ca2+-activated K+ channels in human leukemic T cells
J. Gen. Physiol.
Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin
Proc. Natl. Acad. Sci. U. S. A.
Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology
J. Gen. Physiol.
Potassium channels as therapeutic targets for autoimmune disorders
Curr. Opin. Drug Discov. Dev.
Colocalization and nonrandom distribution of the Kv1.3 potassium channel and CD3 molecules in the plasma membrane of human T lymphocytes
Proc. Natl. Acad. Sci. U. S. A.
Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases
Proc. Natl. Acad. Sci. U. S. A.
Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2
Science
Suppression of the rat microglia Kv1.3 current by src-family tyrosine kinases and oxygen/glucose deprivation
Eur. J. Neurosci.
Molecular properties and physiological roles of ion channels in the immune system
J. Clin. Immunol.
Cited by (389)
Immunosuppressive effects of new thiophene-based K<inf>V</inf>1.3 inhibitors
2023, European Journal of Medicinal ChemistryInterplay of Ca<sup>2+</sup> and K<sup>+</sup> signals in cell physiology and cancer
2023, Current Topics in MembranesInhibitory effect of the selective serotonin reuptake inhibitor paroxetine on human Kv1.3 channels
2021, European Journal of PharmacologyA Molecular Lid Mechanism of K<sup>+</sup> Channel Blocker Action Revealed by a Cone Peptide
2021, Journal of Molecular BiologyTargeting mitochondrial ion channels for cancer therapy
2021, Redox BiologyTranscriptional response of blood leukocytes from turkeys challenged with Salmonella enterica serovar Typhimurium UK1
2021, Veterinary Immunology and Immunopathology